Have a look at our new preprint on alpha-Synuclein acetylation.
www.biorxiv.org/content/10.1...
Have a look at our new preprint on alpha-Synuclein acetylation.
www.biorxiv.org/content/10.1...
We are looking for talented international PhD students and postdoctoral researchers - www.mcgill.ca/edwardfonlab/
Emma MacDougall’s paper showing the interaction between the two PD genes, LRRK2 and GBA1, in human iPSC microglia is now online can01.safelinks.protection.outlook.com?url=https%3A...
Shout out to our collaborators Nicholas Silver and Joel Watts on the paper!
Zaid Al-Azzawi’s paper showing the importance of the alpha-Synuclein purification method on the consistency of the Seed Amplification Assay (SAA) is now online. www.biorxiv.org/cgi/content/...
Ghislaine Deyab’s paper showing that midbrain organoids from patients with Parkinson’s disease exhibit hallmarks of network activity abnormalities seen in vivo is now out on biorxiv. www.biorxiv.org/cgi/content/...
Just got around to closing my X account!
The Quebec government has awarded $1.6M to three McGill researchers to support projects advancing genomics, imaging, and manufacturing. These initiatives will foster collaborations and deliver significant benefits to Quebec and beyond.
➡️ mcgill.ca/x/wr8
A person is pictured walking in front of a building with pillars on Harvard University’s campus in Cambridge, Massachusetts. Headline reads: "Colleges Warn Foreign Students to Get to Campus Before Trump Takes Office." Photo credit: Adam Glanzman for The New York Times.
A number of colleges, including Harvard, USC and Cornell, are advising their international students to return to campus before President-elect Donald Trump is inaugurated on Jan. 20. nyti.ms/41qkzft
Mood in Montreal today.
Lab-grown brain cells help uncover new targets for Parkinson’s treatments.
🧠 Researchers at The Neuro have uncovered a new link between the immune system and the development of the disease.
➡️ mcgill.ca/x/wDZ
Great work! Congratulations to Peter McPherson and Team!
Le Gouvernement du Québec, par l’intermédiaire du CQDM, octroya une subvention de 1,5 million pour la plateforme YCharOS. Ce projet dirigé par les neuroscientifiques @peter-mcpherson.bsky.social et Carl Laflamme, valide des réactifs d’anticorps pour les protéines humaines.
https://buff.ly/3OjmpXD
Félicitations!
Our new paper on Cathepsin B in Parkinson’s just published rdcu.be/d1sJ2